Quinn Everts

How Far Should Community Outreach Go for Pharmacies?

The world continues to become more automated, but how much responsibility should you give AI within your pharmacy?

What does the future of digital health look like?

What is the state of OTC contraception, what’s next for IUDs, and why are so many transgender people denied care?

A look at how the genetics-based research field can become more fully integrated in all areas of health care going forward.

A research article outlines the future of artificial intelligence in health care.

Data presented at Digestive Disease Week show that patients with IBD had less intense post-vaccination symptoms after a fourth dose.

Researchers found an increased occurrence of CDI in individuals who were prescribed antidepressants.

Keeping inventory in pharmacy is already difficult. And keeping stock of dangerous substances like opioids requires even more caution.

Over 400 pharmaceutical employees and executives signed an open letter in a show of solidarity with the FDA, but some say that big pharma’s actions helped lead to this moment in the first place.

A new study from JAPHA explores the link between OUD and social factors.

The drug is a rare FDA-approved liquid formulation that treats ulcers and lowers risk of gastrointestinal bleeding in chronically ill patients.

An increased dose of the diabetes treatment semaglutide caused significant improvement in blood sugar levels and body weight for patients with type 2 diabetes (T2D), according to study results.1 The phase 3 trial PIONEER PLUS was conducted over the span of 68 weeks and included more than 10,000 patients with T2D. “The trial achieved its primary endpoint by demonstrating a statistically significant and superior reduction in HbA1c [hemoglobin A1C] at week 52 with both the 25 mg and 50 mg doses ve…

The drug, branded as Rezzayo, is the first FDA-approved invasive candidiasis treatment in over a decade.

New research examines how individuals with continuing COVID-19 symptoms are managing the virus.

About 1 in 10 individuals in the United States have diabetes. A recent study examines how much they are paying on average for access to treatment for the common disease.

The British pharma giant has teamed up with Johnson for a promotional campaign as they approach the finish line of an RSV vaccine.

According to 2 conference abstracts, CGM’s are effective in treating T2D and chronic kidney disease, but more data may be required to complete the picture.

According to a company press release, the price reductions will go into effect at the start of 2024

The product, called Lenire, uses bimodal stimulation and will be available in April 2023